Vivos (RDGL) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2017)
Vivos (RDGL) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 7.96% |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -62.01% |
| Dec 31, 2016 | -53.77% |
| Sep 30, 2016 | -48.81% |
| Jun 30, 2016 | -45.56% |
| Mar 31, 2016 | -68.38% |
| Dec 31, 2015 | -72.59% |
| Sep 30, 2015 | -74.55% |
| Jun 30, 2015 | -75.14% |
| Mar 31, 2015 | -75.96% |
| Dec 31, 2014 | -76.47% |
| Sep 30, 2014 | -76.63% |
| Jun 30, 2014 | -76.75% |
| Dec 31, 2013 | -76.91% |